Background
Microglia, macrophage-like cells of the brain, are a type of innate immune cell in the central nervous system (CNS). Under normal physiological conditions, microglia are known to secrete neurotrophins and protective cytokines to promote neuronal development and survival. However, upon CNS insult or injury, microglia can acquire complex phenotypes in order to participate in the cytotoxic response, immune regulation, and injury resolution. The classical M1-type activation is associated with cytotoxicity and inflammatory responses, while the alternative M2 activation is regarded as being beneficial [
1]. It has been shown that chronic alcohol drinking activates microglia to an M1 phenotype and promotes inflammatory response [
2]. Activation of microglia to the M1 phenotype is particularly detrimental during the developmental period, as this may lead to neurotoxicity and developmental disorders [
3].
Studies in adult animal models of alcohol abuse provide clues to the effects of ethanol on microglia [
4]. In these models, ethanol administration induces an activated morphological phenotype and stimulates production of pro-inflammatory and neurotoxic molecules. In an adolescent animal model, alcohol exposure increases the risk for persistent and long-lasting increases in brain neuroimmune gene expression and neurodegeneration [
5]. Studies in fetal and neonatal animal model show that ethanol may stimulate neuron cell death, at least in part, through stimulation of neuroinflammatory and neurodegenerative processes in the CNS [
6]. In primary cultures, chronic alcohol increases the release of pro-inflammatory cytokines and oxidative stress molecules from microglia and reduces intracellular cAMP and brain-derived neurotrophic factor in co-cultures of hypothalamic neurons and microglia. Alcohol-activated microglia-conditioned media increases apoptosis in immature hypothalamic neurons [
7‐
9]. Neonatal alcohol exposure in rodents induces neurotoxicity in hypothalamic neurons in vivo [
10]. Alcohol exposure affects the viability of neurons following neonatal alcohol exposure, and peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists limit this ethanol-induced cell loss [
11]. Repeated alcohol exposure during the developmental period may also lead to long-term sensitization of microglia that result in persistent pro-inflammatory signaling in the brain following insult [
12].
Alcohol exposure has many detrimental effects on the developing brain and has been known to cause fetal alcohol spectrum disorders (FASD). Many FASD patients show lifelong stress response abnormalities, as demonstrated by augmented responses to stress hormones such as adrenocorticotropin and corticosterone [
13,
14]. Studies have shown that the abnormalities observed in the stress response of prenatally ethanol-exposed rats appear to be driven by alterations in the functions of the hypothalamic-pituitary-adrenal (HPA) axis [
15], partly due to reduction in the number and function of stress regulatory beta-endorphin (BEP) producing proopiomelanocortin (POMC) neurons in the hypothalamus [
10]. The neurodegenerative effect on POMC neurons by developmental alcohol is connected with alcohol activation of microglia and resultant neuroinflammation [
8,
12].
Recently, it has been shown that microglial activity is tightly controlled by communication between neurons and microglia both under healthy and pathological conditions. Under stress, neurons may release immunomodulatory factors and signaling molecules including neurotransmitters, which may recruit microglia proximally to the affected neurons and induce activation of microglia [
16‐
19]. Mechanisms for the bi-directional communication between activated microglia and neurons may include numerous types of neurotransmitter receptors which are present on microglia [
20]. Because BEP, an opioid peptide, acts via mu- (MOR) and delta- (DOR) opioid receptors, the possibility is raised that these receptors are involved in the communication between POMC neurons and microglia during ethanol toxicity.
Using in vivo neonatal alcohol feeding rat model and in vitro primary cultures of rat hypothalamic microglia and neural stem cell-derived POMC cell models, we evaluated the role of MOR and DOR in ethanol activation of microglia to promote apoptotic action on POMC neurons. We provide evidence that alcohol neurotoxic action on POMC neurons results from differential expression and action of MOR and DOR to promote MOR-activated neuroinflammatory signaling and to reduce DOR-regulated anti-inflammatory signaling in microglia.
Methods
Animals
Adult Sprague-Dawley rats were obtained from Charles River Laboratories (Wilmington, MA). Adult transgenic mice (C57BL/6J) expressing the fluorescent protein EGFP in POMC neurons were obtained from Dr. Malcolm Low’s laboratory at Oregon Health & Sciences University, Portland. All animals were kept under standard lighting conditions (12-h lights on; 12-h lights off) and provided rodent chow and water ad libitum. These rats and mice were bred to generate neonatal animals, which were used in this study. The postnatal day 1 old rat pups were used as the source of fetal rat hypothalamic tissue to prepare microglial cultures. In vivo studies were conducted by feeding rat or mice pups with oral gavage of a milk formula containing 11.34% ethanol (vol/vol) twice daily at 2 h intervals, yielding a total daily ethanol dose of 2.5 g/kg (AF), fed with isocaloric control (PF), or they were left in the litter with the mother (AD) as described by us previously [
10]. The feedings were conducted at 10:00 AM and 12:00 PM daily for 5 days (Postnatal days 2–6). This dose of ethanol gives rise to blood alcohol concentrations of approximately between 150–200 mg/dL. After each feeding, the pups were immediately returned to the litter. Some of the AF animals were additionally received daily s.c treatment with minocycline (45 μg/kg; 1 H prior to the first feeding), MOR antagonist naltrexone (NTX, 10 mg/kg; 15 min prior to the first feeding), or DOR agonist naltrindole (NTD, 10 mg/kg; 15 min prior to the first feeding). All these drugs were purchased from Sigma-Aldrich (St. Louis, MO). Two hours after the last feeding on postnatal day (PND) 6, some of the pups were sacrificed and the mediobasal hypothalamus (the mediobasal portion of the hypothalamus extended approximately 1 mm rostral to the optic chiasma and just caudal to the mammillary bodies, laterally to the hypothalamic sulci, and dorsally to 2 mm deep) was dissected and used for microglia extraction by optiprep gradient separation method or frozen for measurement of protein or gene measurement. Other pups were transcardially perfused, their brains collected, postfixed, cryoprotected, frozen, and cut into 30 μm coronal sections for immunocytochemical studies.
Primary microglial culture
Microglial cells were prepared from PND 1 rat pup hypothalamus (both sexes) using the method described by us previously [
8]. Cells were plated at 2 × 10
5 cells/cm
2. Cultures were fed every 4 days with DMEM/MEM/Hams F12 (HDMEM) in a 4:5:1 ratio with 10% fetal calf serum (FCS). On day 12, the culture was shaken on a rotary shaker at 800 rpm for 1 h. The suspended cells were plated on uncoated T25 flasks and incubated for 1 h at 37 °C. Then, the medium containing suspended cells was discarded and adherent cells were fed with HDMEM for 3 days to develop the microglial culture. To confirm the purity of isolated microglial cells, the culture was stained with IBA-1, a microglial marker or the astrocyte marker glial fibrillary acidic protein (GFAP), and visualized under microscope. The isolated microglial cultures were 99% IBA-1-positive cells considered as pure microglial culture. Microglial cells were maintained in DMEM-F12 with 5% FBS in 24-well plates (1 × 10
5 cells/well) until experimentation. Prior to treatment, microglial cells were fed with DMEM-F12 containing serum supplement (DMEM-F12, 30 nM selenium, 20 nM progesterone, 1 μM iron-free human transferrin, 100 μM putrescine, and 5 μg/ml insulin).
Microglial cells were treated with various doses of ethanol (25–100 mM), [D-Ala 2, N-MePhe 4, Gly-ol]-enkephalin (DAMGO; 50 μM) with or without ethanol (50 mM), [D-Pen2,5]enkephalin (DPDPE; 10 nM) with or without ethanol (50 mM), naltrexone (10 ng/ml) with or without ethanol (50 mM), naltrindole (50 μM) with or without ethanol (50 mM), DAMGO (50 μM) with ethanol (50 mM) and naltrexone (10 ng/ml), DPDPE (10 nM) with ethanol (50 mM) and naltrindole (50 μM), or vehicle for 24 h. All chemicals were purchased form Sigma-Aldrich (St. Louis, MO). After 24 h, media from treated microglial cells were collected, centrifuged, and used for POMC neuronal apoptosis studies or stored at −80 °C for multiplex ELISA and cells were harvested for extraction of proteins. In the immunoneutralization study, microglial cells were pretreated with various neutralizing antibodies (1 ng/ml of anti-TNF-α, T3198, Sigma-Aldrich, St. Louis, MO; 0.5 ng/ml of anti-IL-6, AF506, R&D System, Minneapolis, MN; 5 ng/ml of anti-IL-13, MAS-23735 or 1 ng/ml of anti-IL-4, BVD4-1D11 both from Thermo Fischer, Rockford, IL) 1 h prior to the treatment with ethanol with or without MOR and DOR agonists. After 24 h of incubation, media from treated microglial cells were collected, centrifuged, and used for POMC neuronal apoptosis study.
Preparation of POMC cells from neural stem cells
Enriched POMC neuronal population were prepared by differentiation of neural stem cells in vitro by the methods described by us previously [
21]. In brief, pregnant rats of the Sprague-Dawley strain at 18 to 20 days of gestation were sacrificed, and the fetuses were removed by aseptic surgical procedure. The brains from the fetuses were immediately removed; the hypothalami were separated and placed in ice-cold Hanks’ balanced salt solution containing anti-biotic solution (100 U/ml penicillin, 100 μg/ml streptomycin, and 250 ng/ml amphotericin B), 0.1% bovine serum albumin, and 200 μM ascorbic acid (all from Sigma-Aldrich, St. Louis, MO). The hypothalamic cells were washed and then incubated at 37 °C for 5 min using the same medium. After dispersion, the cells were plated at a density of 3.0 × 10
6 cells per 25-mm
2 flask and at a density of 1.0 × 10
6 cells per well in a 24-well plate. Both the flask and plate were coated with polyornithine at a concentration of 100 μg/ml and then incubated for 3 h. The cells were maintained in Dulbecco’s modified Eagle’s medium with 10% fetal calf serum at 37 °C and 7.5% CO2 in a humidified water-jacketed incubator for 2 days. On day 2, the medium was replaced with HDME containing 10% fetal calf serum, 33.6 μg/ml uridine, and 13.2/ml 5-fluorodeoxyuridine (Sigma-Aldrich, St. Louis, MO) to stop the overgrowth of glial cells. Then, cells were used for the isolation of stem cells for a period of 3 weeks (see for more details, [
21]). These neurospheres were differentiated by treating these cells for 1 week with PACAP (10 μM; SynPep) and dibutyryl cAMP (cAMP; 10 μM; Sigma) in serum-free, chemically defined medium (HDME consisting of 30 nM selenium, 20 nM progesterone, 1 μM iron-free human transferrin, 100 μM putrescine, and 5 μg/ml insulin) and then maintaining them in defined cell culture medium without the drugs for 1 week. These differentiated cells were all stained for POMC derived peptide BEP. During experimentation, POMC cells were cultured (10×
6 cells/well) in T25 flasks for 2 days. The cells were then exposed to conditioned medium from microglia activated with ethanol with or without opioid agonists and antagonists or vehicle for a period of 24 h. Following this cells were lysed with nucleosome lysis buffer and run for nucleosome assay using nucleosome ELISA kit (Calbiochem, USA) for determination of POMC neuronal apoptosis.
In vivo microglial separation and flow cytometry analysis of proteins in microglia
Microglial cells were isolated from the mediobasal hypothalamus of PND 6 pups (both sexes) from three neonatal pups using Optiprep density gradient and methods described previously [
22] with some minor modifications. Briefly, mediobasal hypothalamic tissue samples were isolated and mechanically dissociated using 18-gauge needle followed by a 21-gauge needle in Hank’s balanced salt solution (HBSS) media (Sigma). The cells were strained with 40 μm cell strainer and trypsinized (0.5% trypsin) to digest tissues. The trypsinization reaction was stopped by adding HBSS + 10% FBS media. The cells were strained to get rid of myelin and then loaded on an optiprep column. Optiprep columns were prepared by diluting optiprep with MOPS (3-(N morpholino) propanesulfonic acid) buffer (0.15 M NaCl, 10 mM MOPS, pH 7.4). The diluted optiprep is again diluted in different proportions as 35, 25, 20, and 15% in HBSS media. These solutions were then loaded in a series as most dense on bottom and least dense on top 35, 25, 20, and 15%. Isolated cells were then loaded on top and the columns were centrifuged at 1900 rpm for 15 min at 20 °C. The microglia and red blood cells (RBC) gathered into a pellet at the bottom of the column. The pellets were taken and incubated with 0.85% ammonium chloride to lyse RBCs. The remaining purified microglia were washed with 1× PBS 2 times and fixed with 4% paraformaldehyde for 10 min. The cells were then stained for IBA-1 (microglial marker), GFAP (astrocyte marker), and MAP2 (neuronal marker) to determine the purity of microglia. The isolated microglia were >90% pure.
These purified microglia were used for protein measurements. This was done by flow cytometry analysis. For this, isolated microglia were stained with primary antibodies, rabbit anti-IBA-1 (1:100; Wako Pure Chemical Industries, USA), rabbit anti-DOR (1:100; Santa Cruz, Billerica, MA), rabbit anti-MOR (1:100; Antibodies Inc, Atlanta, GA), mouse anti-TLR4 (1:100; Abcam, Cambridge, MA), rabbit anti-P-38 MAPK, IκBα, P-JNK, and P-AKT (1:100: Cell signaling, Danvers, MA), and mouse anti-NF-κB (1:100, Millipore, Billerica, MA). The cells were labeled with FITC-488 secondary antibody (1:400, Abcam, Cambridge, MA) respective to their primary host and then analyzed by BD Accuri C6 Flow Cytometry. Five thousand events per sample were read for all samples, and data analysis was completed with C6 Accuri software. Flow cytometric gates were set using unstained cells using the forward scatter and side scatter plot, and labeled cells were read on the FL-1A (488) channel. The median fluorescent intensity (MFI) values of positively labeled cells were expressed as mean ± SEM of the entire sample, and data was represented as % AD control for all groups (we normalized the data in this way to account for variation in fluorescent intensities between batches).
Immunohistochemistry
Perfused sections (30 μm) were mounted on Superfrost Plus glass slides (VWR, Radnor, PA,) and stored at −20 °C. The sections were washed in phosphate-buffered saline (PBS) twice followed by two washes in PBS-T (0.05% Triton-X). Then, the sections were incubated with a blocking buffer (2.5% normal horse serum in PBS-T) at room temperature for 60 min. The sections were subsequently incubated overnight at 4 °C with primary antibodies. Primary antibodies for immunohistochemistry were used as follows: goat anti-IBA-1 (1:500; Abcam, Cambridge, MA), rabbit anti-DOR (1:50; Santa Cruz, Billerica, MA), rabbit anti-MOR (1:500; Antibodies Inc., Davis, CA), rabbit anti-GFP (1:2000; Abcam, Cambridge, MA), rabbit anti-ß-endorphin (1:1000, Peninsula Laboratories, Cat#T-4045), and goat anti-POMC (1:400, Santa Cruz, Cat# SC-18262). After the primary antibody incubation and PBS washes, sections were incubated with peroxidase-coupled anti-rabbit (ImmPRESS reagent; Vector Laboratories, Inc., Burlingame, CA) for 3,3′-diaminobenzidine peroxidase (DAB) or Alexa Fluor secondary antibodies (488 and 594; 1:500; Life Technology, Thermo Fisher Scientific, Grand Island, NY) for immunofluorescence. Sections were then mounted with DAPI (Vector Laboratories, Burlingame, CA) and sealed with nail polish. For DAB staining, antigen localization was achieved by using the 3,3′-diaminobenzidine peroxidase reaction (resulting brown staining). After DAB staining, sections were dehydrated in ethanol and mounted in permount (Thermo Fischer Scientific). To evaluate the immunohistochemical staining intensity, animals in each experimental group were photographed using Nikon-TE 2000 inverted microscope (Nikon Instruments Inc., Melville, NY). Pixel density and cell counting were quantified using ImageJ software (National Institutes of Health, Bethesda, MD). To quantify the number of POMC neurons in the arcuate nucleus, serial coronal sections frozen the brains were made using Leica cryostat at 30 μm in thickness from stereotaxic plates 19 to plates 23 (Bregma −2.3 to −4.3 mm) spanning the arcuate nucleus (ARC) area [
23]. Every 4th serial section of the arcuate areas of treated animals was collected and was placed on each slide containing one ad libitum, one pair-fed, or alcohol-fed animal brain section. Pictures were taken using C-1 Confocal Nikon-TE 2000 inverted microscope (Nikon Instruments Inc., Melville, NY). Total numbers of POMC and BEP expressing cells were counted in the ARC and presented as percentage of AD control. For 3D analysis of POMC and microglial interactions, confocal images (Zeiss LSM 710; Oberkochen, Germany) were created using a 20× objective and stacked at 1 mm/step, resulting in 10 mm images. 3D interaction analysis between microglia and POMC neurons was performed using Imaris 8.2 (Bitplane, Concord, MA).
Detection of protein levels by Western blot
Mediobasal hypothalamic tissue samples or microglial cell pellets were used for protein measurements using Western blot procedures. Tissue or cell extracts were processed for protein extraction followed by quantification of total protein levels by Bradford Assay (Bio-Rad Laboratories, Hercules, CA). Protein levels of MOR and DOR were determined by Native-PAGE. Sixty micrograms of protein was loaded for each sample and proteins were resolved using native-PAGE with 10% acrylamide resolving gel. For TNF-α, NF-κB, p38, and IBA-1, Western blot proteins were resolved using SDS-PAGE (Nu-sep, Tris-HEPES; NH-21-420) resolving gel. About 50 μg of total protein was run in 4–20% SDS-PAGE and transferred to nitrocellulose membrane at 30 V overnight at 4 °C. The membranes were blocked in Odyssey Blocking Buffer in PBS (LI-COR Biotechnology, Lincoln, NE) at 4 °C for 5 h or blocked in 5% non-fat dry milk-TBS-0.1% Tween 20 (TBST) at room temperature for 1 h. The membranes were incubated with primary antibody in the same blocking buffer with 0.2% Tween-20 at 4 °C overnight. The primary antibodies used were rabbit anti-Iba-1 (1:400; Wako Pure Chemical Industries, USA), mouse anti-MHC Class II (OX-6) (1:500; Abcam, 55152, Cambridge, MA), rabbit anti-DOR (1:1000; EMD Millipore, Billerica, MA), rabbit anti-MOR (1:5000; EMD Millipore, Billerica, MA), mouse anti-TNF-α (1:1000; Abcam, Cambridge, MA), and mouse anti-actin antibody (1:5000; EMD Millipore, Billerica, MA). Some membranes were washed in PBST (PBS with 0.1% Tween-20) and then incubated with corresponding infrared secondaries (680RD Goat anti-Mouse and 800CW Goat anti-Rabbit IgG, LI-COR Biotechnology, Lincoln, NE) at room temperature for 90 min. The membranes were washed in PBST, and then PBS, and scanned in an Odyssey Infrared Imaging System (LI-COR Biotechnology, Lincoln, NE). Other membranes were washed four times with TBST and then incubated with corresponding peroxidase conjugated secondary antibody (HRP conjugated, 1:1000) at room temperature for 1 h. These membranes were washed six times with TBST and incubated with ECL reagent and were developed on the film by autoradiography. The protein band intensities were determined by Image Studio Lite software (LI-COR Biotechnology, Lincoln, NE) or by ImageJ 1.37v Analysis software (Wayne Rasband, National Institute of Health, USA), and protein expression was normalized with corresponding beta-actin band intensity.
Quantification of chemokines and cytokines in microglial supernatant
Supernatant of microglial cells treated with agents was analyzed for multiple cytokines and chemokines using Bio-Plex Pro rat cytokine assay (Bio-Rad Laboratories, Hercules, CA). All reagents needed for the assays were provided in the kits. Calibration of the instrument was performed for each use, along with regular monthly recommended system validation, and all samples were assayed in duplicate. Data were obtained using the Bio-Plex Manager software program (Bio-Rad version 4.1.1) for standardization and standard curve acquisition.
Quantitative reverse transcription polymerase chain reaction (PCR) for gene expression
Gene expression levels of TLR4, MCP-1, and CSFR1 in the hypothalamic tissues or microglial cells were measured by quantitative real-time PCR (SYBR green assay). Total RNA of each mediobasal hypothalamus sample was extracted using RNeasy purification kit (Qiagen, Valencia, CA) and converted to first-strand complementary DNA (cDNA) using high-capacity cDNA reverse transcription kit (Applied Biosystems, Carlsbad, CA). The following primers were used: Forward/Reverse TLR4 (TGCCTCTCTTGCATCTGGCTGG/CTGTCAGTACCAAGGTTGAGAGCTGG), CSFR1 (GCTCGATGTCCTGCTCTGTGA/CCTGCACTCCATCCATGTCA), MCP1 F/R (GGCCTGTTGTTCACAGTTGCT/TCTCACTTGGTTCTGGTCCAGT), and GAPDH F/R (AGACAGCCGCATCTTCTTGT/CTTGCCGTGGGTAGAGTCAT). RT-PCR was performed at 95 °C for 5 min followed by 45 cycles of 95 °C for 30 s, 62 °C for 30 s, and 72 °C for 40 s in Applied Biosystems 7500 Real-time PCR system (ABI, Carlsbad, CA). Relative quantity of mRNA was calculated by relating the PCR threshold cycle obtained from the tested sample to relative standard curves generated from a serial dilution of cDNA prepared from total cDNA and then quantified as a ratio of GAPDH.
Statistical analysis
Results are expressed as mean ± SEM. One-way ANOVA with the Newman-Keuls post hoc analysis was used to analyze the differences between multiple groups. The value P < 0.05 and onwards was considered significant. Data were analyzed using Prism 5.0 (Graph Pad Software).
Discussion
Fetal alcohol exposure increases POMC neuronal death in the hypothalamus [
10] and results in abnormality in the feedback regulation of stress axis function during a stress challenge [
14,
15,
27,
28], but the mechanism by which POMC neuronal death occurs is not completely understood. In this study, using a rat animal model, we demonstrated that ethanol exposures during the neonatal period, a period equivalent to third trimester of human pregnancy, increase the levels of proinflammatory signaling molecules within the hypothalamus, an area where many POMC neurons are distributed. In addition, we demonstrated an increased number of activated amoeboid microglia (reactive microglia) in the hypothalamus. Activation of microglia towards the amoeboid morphology is known to be associated with inflammatory response, increased cytotoxicity, as well as phagocytosis [
1]. Additionally, we showed enhanced microglial contact with POMC cell soma and decreased hypothalamic POMC cell number, which was reversed by the co-treatment with a microglial activation blocker minocycline. Although minocycline is not a selective microglia blocker [
29], it has a significant inhibitory effect on the inflammatory phase of microglia [
30]. We have used minocycline to determine its ability to block microglia-mediated ethanol action on POMC cells in vivo (Fig.
1n, o). The mediatory role of microglia in ethanol neurotoxic action is consistent with the data of our current (Fig.
6) and our previous in vitro studies [
7‐
9]. We have also observed greater microglial soma interaction with POMC neurons following alcohol feeding, which strongly supports interaction between these two cell types during alcohol exposures. Together, these data suggest that communication between microglia and POMC neurons is important in the establishment of ethanol’s neurotoxic effect on POMC neurons in the hypothalamus during the developmental period.
Recently, it has been shown that the communication between neurons and microglia involves several immunomodulatory factors and signaling molecules including neurotransmitters and their receptors [
20]. POMC neurons produce opioid peptides [
31], and therefore, opioid receptors on microglia may be potential target molecules. Our data provide evidence that a significant level of MOR and DOR proteins is expressed in microglial cells in the hypothalamus and their levels are differentially modulated by ethanol. The presence of MOR in microglia has been previously demonstrated by immunocytochemistry, Western blot, and PCR detections in the CNS [
31]. Some studies detected DOR proteins by immunocytochemistry and RT-PCR in primary cultures of forebrain microglial cells [
32], but others failed to detect DOR proteins by a similar technique in primary microglial cultures from the cortical area of the brain [
33]. We detected both MOR and DOR proteins in microglia derived from the hypothalamus using both immunocytochemistry and flow cytometry methods. The difference between our and Mika et al. [
33] findings might be related to differential characteristics of microglia in various parts of the brain [
34].
The question that arises is what are the physiological ligands for MOR and DOR in ethanol-induced microglial activation and inflammation. Our current study did not investigate the endogenous ligands for MOR and DOR in ethanol-induced microglial activation. However, we could postulate from the published data that BEP cleavage products may play a role in differential activation of MOR and DOR in microglia. This possibility arises since alcohol consumption and inflammation are known to alter endopeptidase activity in the brain [
35,
36] and the production of β-endorphin (BEP) fragments (e.g., BE 1–17, BE 1-18, BE 1-19, BE 20–31; [
37,
38]). Additionally, it has been shown that smaller N-terminal BEP fragments produce higher efficacy to DOR while all BEP fragments produce similar efficacy to MOR [
36]. Additional studies are needed to address this issue.
How ethanol differentially regulates MOR and DOR expression in the microglia? Our data suggest that MOR may be preferentially increased while DOR is not significantly increased on microglia via ethanol, and this may bias the effects of alcohol on the MOR towards a pro-inflammatory M1 effect. We are not certain how ethanol preferentially activate MOR in microglia. One possibility is that ethanol may directly act on microglia to activate MOR. Ethanol may also change endogeneous ligands in the brain to activate MOR in microglia. Further studies are needed to address this issue.
Microglia are able to recognize harmful stimuli and respond by producing inflammatory cytokines such as TNFα, IL-6, IL-1β, IFN-γ, and several chemokines [
39]. This cytokine production is essential for the polarization of microglia into what has been termed a classically activated, “M1” state [
40]. Division of M2 cells is based on observations that stimulation with various cytokines (e.g., IL-4, IL-13) yields different sets of receptor profiles, cytokine production, chemokine secretion, and function (suppression of inflammation) [
41]. Microglial activation and inflammatory molecule expression as a result of ethanol treatment have been well studied during brain development [
12,
42,
43]. It has been shown that high doses of ethanol during the developmental period activate microglia to a pro-inflammatory stage and also increase the expression of neuroinflammatory cytokines and chemokines in diverse regions of the brain. Using both in vivo and in vitro model systems, we showed here that a MOR antagonist, but not a DOR antagonist, prevented alcohol activation of microglia and its production of inflammatory cell signaling molecules in the hypothalamus. Additionally, ethanol and a MOR agonist increased the production of microglial activation markers and inflammatory signaling molecules, while a DOR agonist suppressed alcohol activation of microglia and its production of inflammatory cell signaling molecules in cell cultures. Furthermore, ethanol and a MOR agonist increased secretion of pro-inflammatory cytokines but decreased secretion of anti-inflammatory cytokines, while a DOR agonist decreased secretion of pro-inflammatory cytokines but increased secretion of anti-inflammatory cytokines from microglia. We also showed, using an in vitro cell culture model, that ethanol’s apoptotic effect on POMC neurons is mediated by enhanced pro-inflammatory cytokines like TNF-α and IL-6 produced from microglia, and this effect is promoted by a MOR agonist and suppressed by a MOR antagonist or a DOR agonist. In contrast, ethanol’s apoptotic action on POMC neurons is prevented by DOR-activated production of IL-4 and IL-13. Together, these data suggest that opioid receptors MOR and DOR differentially respond to the ethanol challenge and differentially control the production of inflammatory and anti-inflammatory cytokines from microglia to control POMC neuronal apoptosis.
The pro-inflammatory effect of MOR in microglia within the hypothalamus we observed in this study is consistent with the previous findings that morphine and a MOR receptor agonist DAMGO induce the production of pro-inflammatory signaling molecules (e.g., AKT, NF-κB, MAPK) and increase secretion of pro-inflammatory cytokines (e.g., IL-1b, TNF-α, and IL-6), through Akt and MAPK signaling from forebrain microglia [
43]. Our data are also in agreement with the findings that MOR deficiency can protect against the neuroimmune response in the CNS to ethanol drinking in rats [
44]. Our findings that a DOR agonist induces anti-inflammatory cytokine production and secretion from microglia and prevents ethanol’s apoptotic effects on POMC neurons are also novel and interesting. In this regard, supporting the DOR neuroprotective role is the evidence that DOR activation reversed the hypoxia-induced reduction in BDNF-TrkB signaling and TNF-α secretion in the cortex of hypoxic rats [
45] and produced neuroprotective effects in global cerebral ischemic injury and hypoxic neuronal injury [
46,
47]. Furthermore, it has been shown that, in contrast to MOR activation, DOR activation in the ventral tegmental area protects against elevated alcohol consumption in rat animal models [
48].
Acknowledgements
We thank Nidhi Thakar and Parama Das for the technical assistances in conducting the protein measurements and immunohistochemistry studies.